Tradestie Institutional Equity Comparison Engine

RVT vs HQH โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

HQH Overall Edge

HQH Captures Institutional Edge (1โ€“0 Pillars ยท 2โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to abrdn Healthcare Investors (HQH) driven by superior Momentum & Technical. Fundamentally, RVT trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus HQH at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, RVT sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against HQH sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
RVT N/M vs HQH N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner HQH
1Y +7.5% vs +13.5% ยท 52W Pos 41% vs 52%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
RVT NYSE
Royce Small-Cap Trust, Inc.
Institutional Equity
$16.66
-1.77% 1D
Market Cap $1.9B
1M Return +1.71%
1Y Return +7.48%
Forward P/E N/M
Unified AI Score
47.7 / 100 HOLD
Tech 48.0 Fund 52.0 Flow 50.0 Mom 60.0
HQH NYSE
abrdn Healthcare Investors
Institutional Equity
$21.11
-1.49% 1D
Market Cap $1.0B
1M Return +11.22%
1Y Return +13.49%
Forward P/E N/M
Unified AI Score
48.3 / 100 HOLD
Tech 45.0 Fund 50.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: RVT +7.48% HQH +13.49% Spread: +6.01 pp (HQH Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
RVT TTM Op. Margin: N/A HQH TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RVT vs HQH. Trailing 12-month operating profitability (RVT N/A vs HQH N/A) and valuation multiples (RVT N/M vs HQH N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: RVT (2) vs HQH (2)
Institutional Metric RVT HQH Criterion Row Winner
Market Capitalization Scale $1.9B $1.0B Larger Scale RVT
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A N/A Higher Growth Tie
Operating Margin (TTM) Profitability N/A N/A Higher Margin Tie
Net Profit Margin Profitability N/A N/A Higher Margin Tie
Return on Equity (ROE) Capital Efficiency N/A N/A Higher ROE Tie
52-Week Range Position Momentum 41% ($15โ€“$19) 52% ($17โ€“$25) Stronger Trend HQH
Beta / 30D Volatility Risk Regime 1.03ฮฒ ยท 26% Vol 0.88ฮฒ ยท 40% Vol Lower Realized Risk RVT
Unified Institutional Score Composite Signal 47.7 / 100 (HOLD) 48.3 / 100 (HOLD) Higher Composite HQH

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full RVT vs HQH Buy Guide
RVT UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live RVT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
HQH UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live HQH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither RVT nor HQH registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.